Testing effectiveness (Phase 2)UnknownNCT03015623
What this trial is testing
Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy
Who this might be right for
Acute Kidney Injury
Sentien Biotechnologies, Inc. 24